Christopher J. Forlenza

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

Kevin J. Curran, Steven Margossian, Nancy A. Kernan et al. · Blood · 2019 · 272 citations · Full text

Cell Therapy, Mixed-phenotype Acute Leukemia, Immunology +18

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Elise Fiala, Gowtham Jayakumaran, Audrey Mauguen et al. · Nature Cancer · 2021 · 156 citations · Full text

Tumoral Pathology, Medicine, Cancer Management +5

Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation

Brian C. Shaffer, Jean-Benoît Le Luduec, Christopher J. Forlenza et al. · Biology of Blood and Marrow Transplantation · 2016 · 151 citations · Full text

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino et al. · New England Journal of Medicine · 2024 · 150 citations · Full text

Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted <scp>EPOCH</scp>‐R

Lisa Giulino‐Roth, Tara J. O’Donohue, Zhengming Chen et al. · British Journal of Haematology · 2017 · 123 citations · Full text